Samsara Inc
NYSE:IOT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Samsara Inc
NYSE:IOT
|
US |
|
I
|
Invicta Holdings Ltd
JSE:IVT
|
ZA |
|
Pearson PLC
LSE:PSON
|
UK |
|
C
|
Cosa Resources Corp
OTC:COSAF
|
CA |
|
Tarsus Pharmaceuticals Inc
NASDAQ:TARS
|
US |
|
CDS Co Ltd
TSE:2169
|
JP |
|
B
|
Beijing Jiuzhou yi gui Environmental Technology Co Ltd
SSE:688485
|
CN |
|
I
|
Indsil Hydro Power and Manganese Ltd
BSE:522165
|
IN |
|
Perimeter Medical Imaging AI Inc
XTSX:PINK
|
CA |
|
Nexity SA
F:NQ9
|
FR |
|
Lam Research Corp
NASDAQ:LRCX
|
US |
|
C
|
C&G Hi Tech Co Ltd
KOSDAQ:264660
|
KR |
|
Euroz Hartleys Group Ltd
ASX:EZL
|
AU |
|
Rocket Lab USA Inc
NASDAQ:RKLB
|
US |
|
A
|
Advenica AB (publ)
STO:ADVE
|
SE |
|
Mangalore Chemicals and Fertilisers Ltd
NSE:MANGCHEFER
|
IN |
|
Mary Chia Holdings Ltd
SGX:5OX
|
SG |
Balance Sheet
Balance Sheet Decomposition
Samsara Inc
Samsara Inc
Balance Sheet
Samsara Inc
| Feb-2020 | Jan-2021 | Jan-2022 | Jan-2023 | Feb-2024 | Feb-2025 | Jan-2026 | ||
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Cash Equivalents |
201
|
400
|
921
|
201
|
136
|
228
|
319
|
|
| Cash Equivalents |
201
|
400
|
921
|
201
|
136
|
228
|
319
|
|
| Short-Term Investments |
0
|
0
|
0
|
489
|
412
|
467
|
515
|
|
| Total Receivables |
34
|
42
|
82
|
123
|
162
|
234
|
321
|
|
| Accounts Receivables |
34
|
42
|
82
|
123
|
162
|
234
|
321
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
17
|
14
|
33
|
41
|
22
|
39
|
48
|
|
| Other Current Assets |
26
|
35
|
64
|
104
|
155
|
177
|
304
|
|
| Total Current Assets |
277
|
491
|
1 100
|
958
|
887
|
1 145
|
1 507
|
|
| PP&E Net |
202
|
191
|
171
|
172
|
137
|
123
|
142
|
|
| PP&E Gross |
202
|
191
|
171
|
172
|
137
|
123
|
0
|
|
| Accumulated Depreciation |
6
|
14
|
22
|
34
|
52
|
66
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
113
|
276
|
283
|
403
|
|
| Other Long-Term Assets |
151
|
205
|
297
|
374
|
435
|
473
|
489
|
|
| Total Assets |
631
N/A
|
887
+41%
|
1 568
+77%
|
1 617
+3%
|
1 735
+7%
|
2 024
+17%
|
2 541
+26%
|
|
| Liabilities | ||||||||
| Accounts Payable |
16
|
19
|
55
|
30
|
46
|
64
|
48
|
|
| Accrued Liabilities |
37
|
49
|
80
|
112
|
119
|
134
|
190
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
94
|
143
|
203
|
300
|
426
|
563
|
679
|
|
| Total Current Liabilities |
148
|
212
|
338
|
442
|
592
|
761
|
917
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
284
|
258
|
241
|
237
|
228
|
194
|
203
|
|
| Total Liabilities |
432
N/A
|
470
+9%
|
579
+23%
|
679
+17%
|
820
+21%
|
955
+17%
|
1 120
+17%
|
|
| Equity | ||||||||
| Common Stock |
540
|
949
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
346
|
566
|
921
|
1 168
|
1 455
|
1 610
|
1 619
|
|
| Additional Paid In Capital |
5
|
33
|
1 910
|
2 107
|
2 369
|
2 680
|
3 035
|
|
| Other Equity |
0
|
0
|
0
|
1
|
2
|
1
|
4
|
|
| Total Equity |
199
N/A
|
416
+110%
|
989
+138%
|
938
-5%
|
915
-2%
|
1 069
+17%
|
1 420
+33%
|
|
| Total Liabilities & Equity |
631
N/A
|
887
+41%
|
1 568
+77%
|
1 617
+3%
|
1 735
+7%
|
2 024
+17%
|
2 541
+26%
|
|
| Shares Outstanding | ||||||||
| Common Shares Outstanding |
500
|
500
|
505
|
524
|
546
|
566
|
577
|
|